JESSICA BRANDON: Open Payments
NPI 1578721981 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 21 payments from 11 companies in 2025. Trend: 2023 $423 · 2024 $536 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $106 |
| ABBVIE INC. | 4 | $96 |
| PFIZER INC. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| ABIOMED | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $19 |
| SANOFI PASTEUR INC. | 1 | $17 |
Products named: NURTEC ODT, Wegovy, UBRELVY, SHINGRIX, EPIDIOLEX, QULIPTA, CAPLYTA, VRAYLAR.
Industry payments across CO — which companies pay providers there.
